Simply Good Foods Co financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Simply Good Foods Co files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue		438	524	817	1,006	1,169	1,243	1,331	1,451	1,356
Cost of revenue		255	306	492	596	723	789	820	925	914
Gross profit		183	218	324	410	446	453	512	526	442
Research and development		2.5	2.2	4	3.5	4.1	4.3	5.4	5.5	5.9
Selling and marketing		59.2	67.7	94.5	113	122	119	144	134	129
General and administrative		49.4	62.2	106	106	104	112	130	156	144
Operating expenses		116	145	246	236	243	248	305	369	622
Operating income		67.4	72.7	78.2	174	203	205	206	157	-180
Interest expense		12.6	13.6	32.8	31.6	21.9	30.1	26	23.2	21.4
Interest income		0	3.83	1.52	0.08	0.02	1.14	4.31	2.66	2.94
Other non-operating income		-46	-81.2	0.74	-92.8	-52.2	-29.3	-20.4	-21	-18.4
Pre-tax income		21.3	-8.52	79	80.9	151	176	186	136	-198
Income tax		-16.1	16.7	13.3	40	42	42.1	46.7	32.3	-42.2
Net income	10	37.4	-25.2	65.6	40.9	109	134	139	104	-156
EBITDA		75	80.3	94.2	192	222	225	227	178	-155
EPS, basic		0.53	-0.31	0.70	0.43	1.10	1.34	1.39	1.03	-1.69
EPS, diluted		0.51	-0.31	0.35	0.42	1.08	1.32	1.38	1.02	-1.69
Shares, basic (weighted)		70.6	80.7	94	95.7	98.8	99.4	99.9	101	92.4
Shares, diluted (weighted)		72.8	80.7	98.3	97.4	101	101	101	102	92.4

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	78.5	112	266	95.8	75.3	67.5	87.7	133	98.5	138
Receivables	42.8	36.6	44.2	89.7	111	133	145	151	165	137
Inventory	27.5	30	38.1	59.1	97.3	125	117	142	167	132
Other current assets	8.35	5.08	6.06	11.9	9.69	20.9	16	9.19	15.8	18.1
Total current assets	159	186	358	260	299	352	372	440	454	434
Property, plant and equipment	2.27	2.57	2.46	11.9	16.6	18.2	24.9	24.8	39.7	52.6
Lease right-of-use assets				25.7	46.2	46.5	40	35.1	44.1
Goodwill	40.7	471	471	545	543	543	543	592	590	552
Intangible assets	186	313	306	1,159	1,139	1,123	1,108	1,336	1,262	953
Other non-current assets	1.85	2.23	4.02	32.8	54.8	58.1	49.3	42.9	51	45.6
Total assets	390	975	1,142	2,008	2,052	2,094	2,097	2,436	2,396	2,037
Accounts payable	18.8	11.2	15.7	32.2	59.7	62.1	52.7	58.6	78.3	45.1
Accrued liabilities				38	53.6	39.7	35.1	49.8	46.2	32.7
Short-term debt	11.4	0.65	0.68	0.27	0.29	0.26	0.14	0
Total current liabilities	50.8	30.6	48	71.5	114	102	89.9	109	125	77.8
Long-term debt	322	191	190	597	451	403	282	397	249	347
Lease liabilities				22.8	44.9	44.5	37.3	34.3	49.5
Other non-current liabilities		0.86	0.53	22.8	44.9	44.6	38.3	36.5	49.5	42.6
Total liabilities	417	302	429	869	863	656	526	709	589	584
Total debt	333	192	191	597	452	403	282	397	249	347
Paid-in capital	-43.6	596	716	1,076	1,085	1,287	1,303	1,320	1,347	1,363
Retained earnings	16.2	24.5	-0.71	64.9	106	214	348	487	591	435
Treasury stock		0	-2.15	-2.15	-2.15	-62	-78.5	-78.5	-129	-345
Other comprehensive income	-0.44	-0.8	-0.84	-0.88	-0.82	-1.95	-2.59	-2.04	-2.43	-1.55
Shareholders' equity	-27.8	621	713	1,139	1,189	1,439	1,571	1,727	1,807	1,452
Total equity	-27.8	621	713	1,139	1,189	1,439	1,571	1,727	1,807	1,452
Total liabilities and equity	390	975	1,142	2,008	2,052	2,094	2,097	2,436	2,396	2,037
Shares outstanding		70.6	81.9	95.7	95.8	99.5	99.6	100	99.7	88.5

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	10	37.4	-25.2	65.6	40.9	109	134	139	104	-156
Depreciation and amortization	1.1	7.67	7.64	16	18.2	19.3	20.3	21	21.4	24.3
Stock-based compensation		4.03	5.5	7.64	8.27	11.7	14.5	18.4	15.3	17.3
Deferred income tax		-20.3	10.9	8.22	9.4	11.8	10.6	8.37	0	-49.5
Change in receivables		-6.16	-8.36	-18.3	-22.3	-21.8	-13.4	9.13	-14.7	28.3
Change in inventory		2.43	-8.18	23.9	-39.3	-29.5	8.17	13.7	-25.8	35.9
Change in payables		-3.6	4.73	-8.74	25.9	2.88	-9.51	-15.5	18.5	-33.2
Cash from operations		61	73	58.9	132	111	171	216	178	181
Capital expenditures		-1.77	-1.04	-1.74	-5.91	-5.23	-11.6	-5.74	-20.5	-24.1
Acquisitions						0	0	280	-1.71	0
Cash from investing		-3.51	-1.79	-984	-2.51	-8.16	-12.2	-287	-20.9	-24.1
Debt issued		0	0	460	0	0	0	250	0	150
Debt repaid		-1.5	-2	-50	-150	-50	-122	-135	-150	-50
Stock issued		0	0	353	0	0	5.25	4.29	12.9	1.06
Share buybacks		0	-2.15	0	0	-59.9	-16.4	0	-50.9	-213
Cash from financing		-1.59	83.4	755	-150	-110	-139	116	-191	-117
Exchange rate effect		-0.47	-0.26	-0.07	-0.04	-0.3	-0.18	0.09	-0.38	0.2
Net change in cash				-170	-20.5	-7.55	20.4	44.7	-33.7	39.8
Free cash flow		59.3	72	57.2	126	105	160	210	158	157
Interest paid		11.2	11.2	30	27.8	19.2	25.5	25.7	22	20.8
Income taxes paid		4.58	7.45	4.53	32.2	49.2	27.4	33.2	39.3	15.4

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $12.60 on November 9, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.6%	Gross profit / revenue.
Operating margin	-13.2%	Operating income / revenue.
EBITDA margin	-11.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-14.6%	Pre-tax income / revenue.
Net margin	-11.5%	Net income / revenue.
FCF margin	11.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	13.3%	Cash from operations / revenue.
Return on equity (ROE)	-9.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-7.0%	Net income / average total assets.
Return on invested capital (ROIC)	-7.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.4%	Research and development expense / revenue.
Stock-based pay / revenue	1.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.8%	Capital expenditures / revenue.
D&A / revenue	1.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-6.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	3.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-15.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	1.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-214.6%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-187.2%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-250.5%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-265.7%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	1.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	1.9%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-0.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-0.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	4.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-19.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-2.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-15.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-9.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	5.57x	Current assets / current liabilities.
Quick ratio	3.54x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.78x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.24x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	17.0%	Total debt / total assets.
Liabilities / assets	28.7%	Total liabilities / total assets.
Net debt	$208.8M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-8.38x	Operating income / interest expense.
Working capital	$355.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	73.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$52.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.61x	Revenue / average total assets.
Fixed asset turnover	29.4x	Revenue / average property, plant and equipment.
Inventory turnover	6.10x	Cost of revenue / average inventory.
Days inventory	60 days	365 x average inventory / cost of revenue.
Receivables turnover	8.98x	Revenue / average receivables.
Days sales outstanding	41 days	365 x average receivables / revenue.
Days payables	25 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	76 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	13.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.69	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$1.69	Net income per basic share, as reported (split-adjusted).
Revenue per share	$14.69	Revenue / diluted weighted shares.
FCF per share	$1.70	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.96	Cash from operations / diluted weighted shares.
Book value per share	$16.42	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.59	Tangible book value / shares outstanding.
Cash per share	$1.56	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	135.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.11B	Share price x shares outstanding.
Enterprise value	$1.32B	Market cap + total debt - cash - short-term investments.
P/S	0.82x	Market cap / revenue.
P/B	0.77x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	7.10x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.16x	Market cap / cash from operations, when positive.
EV/Sales	0.98x	Enterprise value / revenue.
EV/FCF	8.43x	Enterprise value / free cash flow, when both are positive.
FCF yield	14.1%	Free cash flow / market cap.
Earnings yield	-14.0%	Net income / market cap (the inverse of P/E).
Shareholder yield	19.1%	(Dividends paid + share buybacks) / market cap.

What was Simply Good Foods Co's revenue in fiscal 2026?

Simply Good Foods Co reported revenue of $1.36B for fiscal 2026, 6.5% lower than the year before.

Was Simply Good Foods Co profitable in fiscal 2026?

No. It reported a net loss of $155.9M.

How much free cash flow did Simply Good Foods Co generate in fiscal 2026?

Cash from operations of $181.0M minus capital expenditures of $24.1M left free cash flow of $156.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Simply Good Foods Co